Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hennessy

Showing results (181-190 of 249) with videos related to

Pageof 25
Sort By:
Breast Cancer Research and Treatment|September 14, 2015
Economic impact of 21-gene recurrence score testing on early-stage breast cancer in IrelandLillian Smyth, Geoff Watson, Elaine M Walsh, et al.
Lung Cancer (Amsterdam, Netherlands)|May 8, 2022
Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panelDaniel J Ryan, Sinead Toomey, Robert Smyth, et al.
The Journal of Molecular Diagnostics : JMD|December 22, 2018
Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity TestingChristina Grimm, Axel Fischer, Angela M Farrelly, et al.
Breast Cancer Research : BCR|June 24, 2010
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J Creighton, Xiaoyong Fu, Bryan T Hennessy, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
International Journal of Dermatology|September 12, 2025
Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ MalignanciesDavid O'Reilly, Gregg Murray, Orla M Fitzpatrick, et al.
The Oncologist|August 26, 2025
Implementation of Neoadjuvant Immunotherapy in Stage III Melanoma: A Modified Delphi Consensus Study in a European-accredited cancer Centre in IrelandChristopher Cronin, Fiachra Martin, James D Martin-Smith, et al.
Oncogene|July 12, 2011
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal fillingC-R Pradeep, W J Köstler, M Lauriola, et al.
Cancer Cell|October 16, 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancerKatrien Berns, Hugo M Horlings, Bryan T Hennessy, et al.
Molecular Oncology|February 19, 2013
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutationBritta Stordal, Kirsten Timms, Angela Farrelly, et al.
Pageof 25

Showing results (181-190 of 249) with videos related to

Sort By:
Pageof 25
Breast Cancer Research and Treatment|September 14, 2015
Economic impact of 21-gene recurrence score testing on early-stage breast cancer in IrelandLillian Smyth, Geoff Watson, Elaine M Walsh, et al.
Lung Cancer (Amsterdam, Netherlands)|May 8, 2022
Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panelDaniel J Ryan, Sinead Toomey, Robert Smyth, et al.
The Journal of Molecular Diagnostics : JMD|December 22, 2018
Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity TestingChristina Grimm, Axel Fischer, Angela M Farrelly, et al.
Breast Cancer Research : BCR|June 24, 2010
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J Creighton, Xiaoyong Fu, Bryan T Hennessy, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
International Journal of Dermatology|September 12, 2025
Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ MalignanciesDavid O'Reilly, Gregg Murray, Orla M Fitzpatrick, et al.
The Oncologist|August 26, 2025
Implementation of Neoadjuvant Immunotherapy in Stage III Melanoma: A Modified Delphi Consensus Study in a European-accredited cancer Centre in IrelandChristopher Cronin, Fiachra Martin, James D Martin-Smith, et al.
Oncogene|July 12, 2011
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal fillingC-R Pradeep, W J Köstler, M Lauriola, et al.
Cancer Cell|October 16, 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancerKatrien Berns, Hugo M Horlings, Bryan T Hennessy, et al.
Molecular Oncology|February 19, 2013
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutationBritta Stordal, Kirsten Timms, Angela Farrelly, et al.
Pageof 25